Product Overview

ZyhCG 10000 is a pharmaceutical preparation that contains human chorionic gonadotropin (HCG) at a strength of 10,000 international units per vial. It is manufactured by German Remedies Private Ltd and is supplied in a single‑use glass vial that is packaged in a protective box. The product falls under the therapeutic category of female infertility and is intended for use under the supervision of a qualified health professional. The active ingredient, HCG, mimics the natural luteinizing hormone that stimulates the ovaries to produce mature follicles and triggers ovulation. This medication is delivered in a sterile, lyophilized form that must be reconstituted with a suitable diluent before administration. The recommended storage conditions are refrigerated (2‑8 °C) and the product should be used before the expiration date indicated on the label.

What is ZyhCG 10000 (HCG 10000iu)

ZyhCG 10000 refers to a specific dosage form of HCG that provides 10,000 IU of the hormone per vial. The term “ZyhCG” is the brand name used by the manufacturer, while the scientific designation highlights the concentration of the active moiety. HCG is a glycoprotein hormone produced by the placenta during pregnancy, but it can also be synthesized in a laboratory setting for therapeutic purposes. In the context of reproductive medicine, the hormone is employed to stimulate the hypothalamic‑pituitary axis, leading to the development and release of mature follicles and triggers ovulation. The 10,000‑IU potency is a standard dose used in many fertility protocols, particularly for ovulation induction and controlled ovarian hyperstimulation. The product is classified as a prescription‑only medication and should only be obtained with a valid medical prescription.

Uses and Benefits

The primary indication for ZyhCG 10000 is the treatment of female infertility associated with anovulation or oligo‑ovulation. Clinically, it is used to induce ovulation in women who do not naturally release mature eggs, often as part of assisted reproductive techniques such as intrauterine insemination (IUI) or in‑vitro fertilization (IVF). The benefits of treatment include an increased chance of conception per menstrual cycle, better synchronization of follicular development, and improved odds of successful pregnancy when combined with other fertility interventions. In addition, HCG therapy can help diagnose certain hormonal disorders by measuring the hormone’s levels in serum or urine. Physicians may also use the drug off‑label for purposes such as weight management, but such uses are not approved by regulatory agencies and should be approached with caution.

How It Works

ZyhCG 10000 functions by binding to the LH (luteinizing hormone) receptors on ovarian cells, thereby mimicking the natural surge of LH that occurs mid‑cycle. This binding triggers the final maturation of the ovarian follicles and stimulates the rupture of the dominant follicle, releasing the oocyte into the peritoneal cavity. The hormone also supports the corpus luteum, ensuring adequate progesterone production in the early weeks after fertilization, which is essential for maintaining the uterine lining. Because HCG has a similar structure to LH, it can activate the same signaling pathways, leading to the production of androgens in theca cells and their subsequent conversion to estrogen in granulosa cells. The pharmacodynamics of HCG involve a half‑life of approximately 30 hours after injection, allowing for a relatively sustained biologic effect.

Dosage Guidelines

Dosage of ZyhCG 10000 must be individualized based on the patient’s medical history, ovarian reserve, and response to prior therapy. Typical clinical protocols involve a single intramuscular or subcutaneous injection of one vial (10,000 IU) when the leading follicle reaches an appropriate size, usually between 18‑22 mm on ultrasound. In some protocols, a split dose may be administered to reduce the risk of ovarian hyperstimulation syndrome (OHSS). It is essential that the reconstitution be performed with a sterile diluent, and the injection should be given under clean conditions to avoid infection. Patients should be instructed to avoid excessive physical activity immediately after the injection and to report any unusual symptoms to their healthcare provider. Because dosing can vary widely, the prescribing clinician will determine the exact schedule and any necessary adjustments.

Side Effects

Like all hormonal medications, ZyhCG 10000 can be associated with a range of adverse effects, most of which are mild to moderate. Common side effects include headache, nausea, abdominal discomfort, and injection‑site reactions such as redness or swelling. Some patients may experience mood changes, breast tenderness, or bloating due to fluid retention. Rare but serious complications can involve ovarian hyperstimulation syndrome, characterized by severe abdominal pain, rapid weight gain, and shortness of breath, which requires immediate medical attention. Allergic reactions, although uncommon, may present as rash, itching, or difficulty breathing. Patients should be counseled to seek emergency care if they experience chest pain, severe dizziness, or signs of a blood clot.

Warnings and Precautions

ZyhCG 10000 is contraindicated in individuals with known hypersensitivity to HCG or any of the excipients in the formulation. The drug should not be used in patients with active or suspected ovarian, breast, or uterine cancers, as well as in those with thyroid disorders that are not adequately controlled. Caution is advised for patients with a history of thromboembolic disorders, as HCG may increase the risk of clot formation. Pregnant women must not receive the medication, as it could potentially harm the developing fetus. Prior to initiation, a thorough medical evaluation, including laboratory tests and imaging, should be performed to assess ovarian function and rule out underlying pathologies. Concomitant use of other gonadotropins or hormonal therapies should be reviewed with a physician to avoid drug interactions.

Frequently Asked Questions

1. What is the recommended storage condition for ZyhCG 10000?

Store the vial in a refrigerator between 2 °C and 8 °C, protect it from light, and do not freeze. Once reconstituted, the solution can be kept at room temperature for a limited period as specified in the product insert.

2. How long does it take for ovulation to occur after an HCG injection?

Ovulation typically occurs within 12‑36 hours after administration of the trigger dose, although individual response may vary depending on follicular development and patient factors.

3. Can ZyhCG 10000 be used for male infertility?

While HCG is occasionally used off‑label in male fertility regimens to stimulate testosterone production, this application is not the primary indication of ZyhCG 10000 and should only be pursued under specialist supervision.

4. Is it safe to use ZyhCG 10000 if I have a history of polycystic ovary syndrome (PCOS)?

Patients with PCOS can use HCG, but they may be at higher risk for OHSS; therefore, dosing must be carefully titrated and monitored by a qualified clinician.

5. Where can I find more detailed prescribing information?

Comprehensive details are available on the official product label, as well as on trusted medical resources such as the U.S. Food and Drug Administration and the National Institutes of Health.

Related Products

• Azelastine Nasal Spray (Generic)
• Arzep Nasal Spray (Azelastine)
• Vigora 100 mg (Sildenafil Citrate)
• Vigora Tablet (Sildenafil Citrate)
• Vigora Lido Spray (Lidocaine)
• Vigore Gold 100 mg (Sildenafil Citrate)
• Vigore Force 80 mg (Sildenafil/Dapoxetine)
• Tadora 20 mg (Tadalafil)
• Vigora 50 mg (Sildenafil Citrate)
• Tadora Force 80 mg(Tadalafil/Dapoxetine)
• ZyhCG 5000 (HCG 5000iu)
• ZyhCG 2000 (HCG 2000iu)